Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1600bd7a2bd0638198d6e1a3b8e09b91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4f405b09418d03164df8f1817f49cda http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2325e291ffd61a2c34633357154def32 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16 |
filingDate |
1991-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2000-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9c9a69375684a4c56a360b0eb13345e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98e06c5d5dee935f27050ee9848765b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d743b11f54898961ba9ae94bd61a3ce |
publicationDate |
2000-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0563244-B1 |
titleOfInvention |
Human phospholipase activating protein portion |
abstract |
The invention provides methods for detecting elevated levels of phospholipase A2 activating protein in persons suspected of having rheumatoid arthritis to thereby indicate the presence of rheumatoid arthritis in the person comprising the steps of providing a sample of body fluid or tissue from said person; contacting the sample with an antibody specific for phospholipase A2 activating protein such that the antibody binds with phospholipase A2 activating protein in the sample; detecting the antibody thereby indicating the presence of phospholipase A2 activating protein, whereby elevated levels of phospholipase A2 activating protein in the sample as compared with levels found in persons not having rheumatoid arthritis indicates the presence of rheumatoid arthritis in the person. Kits and reagents for detecting rheumatoid arthritis are also provided. |
priorityDate |
1990-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |